Skip to main content

Jack Mann

Analyst

Needham

Equibles does not estimate personal net worth.

About Jack Mann

Jack Mann is recorded as Analyst at Needham. Jack Mann has spoken on 1 earnings call across 1 company, most recently for Illumina, Inc. on February 5, 2026. The companies whose calls Jack Mann spoke on are classified in the Healthcare sector.

Jack Mann on recent calls

“I wanted to build on Dan's question there, just continue on the path of AGBT. It seems like on the competitive front, you know, at least one competitor has talked about the $100 price point per genome.”
Analyst — Needham, Illumina, Inc. Q4 FY2025 Earnings Call ·

Affiliation history

  • Needham

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity